Viking Wins First Round In Legal Battle With Ascletis Over THRβ Agonist

Both Firms Pursuing MASH Candidates

trade secrets
Viking lodged ITC action against Ascletis in 2022, alleging unlawful and unfair methods of competition • Source: Shutterstock

More from Alimentary/Metabolic

More from Therapy Areas